Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Sex hormones are crucial in the development and progression of various cancers, including breast, ovarian, and prostate cancers.
• Hormone-targeting therapies are effective but often face challenges with tumor resistance.
• Identifying downstream effectors of sex hormones is vital for developing novel cancer treatment strategies.

Purpose of the Study:

• To review the role of Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) as a mediator of steroid hormone action in hormone-dependent cancers.
• To examine the evidence supporting GREB1's involvement in breast, ovarian, prostate, and endometrial cancers.
• To assess the potential of GREB1 as a therapeutic target for these malignancies.

Main Methods:

• Literature review of studies investigating GREB1 expression and function in hormone-dependent cancers.
• Analysis of GREB1's responsiveness to estrogen, androgen, and progesterone.
• Examination of GREB1's role in cancer cell proliferation and its correlation with hormone levels.

Main Results:

• GREB1 is an early estrogen-responsive gene, with expression linked to estrogen levels in breast cancer.
• GREB1 also responds to androgens in prostate cancer and progesterone in endometrial cells, indicating it's a pan steroid-responsive gene.
• GREB1 has been shown to stimulate the proliferation of breast, ovarian, and prostate cancer cells.

Conclusions:

• GREB1 is implicated as a significant mediator in multiple hormone-dependent cancers.
• GREB1's pan steroid-responsive nature makes it a promising target for developing new therapeutic strategies.
• Targeting GREB1 could overcome resistance mechanisms and improve treatment outcomes for patients with hormone-dependent cancers.